Skip to content
healthcare.dev

Taraxacum Officinale

NDC 37662-1295, Taraxacum Officinale, pellet, from Hahnemann Laboratories, INC..

Product NDC
37662-1295
Status
Listed
Labeler
Hahnemann Laboratories, INC.
Dosage form
PELLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/37662-1295 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TARAXACUM OFFICINALE30 [hp_C]/1
Package NDCNDC-11Package
37662-1295-13766212950180 PELLET in 1 VIAL, GLASS (37662-1295-1)
37662-1295-237662129502200 PELLET in 1 VIAL, GLASS (37662-1295-2)
37662-1295-3376621295031200 PELLET in 1 BOTTLE, GLASS (37662-1295-3)
37662-1295-4376621295044000 PELLET in 1 BOTTLE, GLASS (37662-1295-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 37662-1295 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/37662-1295 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 37662-1295. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.